Skip to main content
SpringerLink
Log in

Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy

  • CLINICAL CORRESPONDENCE
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Abraham SC, DeNofrio D, Loh E, Minda JM, Tomaszewski JE, Pietra GG, Reynolds C (1998) Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy. Hum Pathol 29:876–882

    Article  PubMed  CAS  Google Scholar 

  2. Arbustini E, Morbini P, Grasso M, Fasani R, Verga L, Bellini O, Dal Bello B, Campana C, Piccolo G, Febo O, Opasich C, Gavazzi A, Ferrans VJ (1998) Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol 31:645–653

    Article  PubMed  CAS  Google Scholar 

  3. Arbustini E, Pasotti M, Pilotto A, Pellegrini C, Grasso M, Previtali S, Repetto A, Bellini O, Azan G, Scaffino M, Campana C, Piccolo G, Viganò M, Tavazzi L (2006) Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 8:477–483

    Article  PubMed  CAS  Google Scholar 

  4. Berger PB, Duffy J, Reeder GS, Karon BL, Edwards WD (1994) Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc 69:162–165

    PubMed  CAS  Google Scholar 

  5. Bertini E, Bosman C, Bevilacqua M, Ricci E, Gagliardi GM, Parisi F, Servidei S, Dionisi-Vici C, Ballerini L (1990) Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr 149:856–858

    Article  PubMed  CAS  Google Scholar 

  6. Campos Y, Martín MA, Caballero C, Rubio JC, de la Cruz F, Tuñón T, Arenas J (2000) Single large-scale mitochondrial DNA deletion in a patient with encephalopathy, cardiomyopathy, and prominent intestinal pseudo-obstruction. Neuromuscul Disord 10: 56–58

    Article  PubMed  CAS  Google Scholar 

  7. El-Menyar AA, Al-Suwaidi J, Gehani AA, Bener A (2004) Clinical and histologic studies of a Qatari family with myofibrillar myopathy. Saudi Med J 25:1723–1726

    PubMed  Google Scholar 

  8. Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA (2007) PROactive investigators. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). Diabetes Care 30:2773–2778

    Article  PubMed  CAS  Google Scholar 

  9. Finsterer J, Stöllberger C, Avanzini M, Rauschka H (2006) Restrictive cardiomyopathy in dermatomyositis. Scand J Rheumatol 35:229–232

    Article  PubMed  CAS  Google Scholar 

  10. Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452

    Article  PubMed  CAS  Google Scholar 

  11. Ishiwata S, Nishiyama S, Seki A, Kojima S (1993) Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 57:928–933

    PubMed  CAS  Google Scholar 

  12. Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb-Peploe MM (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235

    Article  PubMed  CAS  Google Scholar 

  13. Ligi I, Fraisse A, Chabrol B, Paut O, Bourlon F, Métras D, Bonnet JL, Pellissier JF (2003) Restrictive cardiomyopathy due to myofibrillar myopathy. Arch Pediatr 10:432–435

    Article  PubMed  CAS  Google Scholar 

  14. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298:1180–1188

    Article  PubMed  CAS  Google Scholar 

  15. Pruszczyk P, Kostera-Pruszczyk A, Shatunov A, Goudeau B, Dramiñska A, Takeda K, Sambuughin N, Vicart P, Strelkov SV, Goldfarb LG, Kamiñska A (2007) Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. Int J Cardiol 117:244–253

    Article  PubMed  Google Scholar 

  16. Rottlaender D, Michels G, Erdmann E, Hoppe UC (2007) Therapy with glitazones—a risk for cardiovascular disease? Dtsch Med Wochenschr 132: 2629–2632

    Article  PubMed  CAS  Google Scholar 

  17. Sabatelli M, Bertini E, Ricci E, Salviati G, Magi S, Papacci M, Tonali P (1992) Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J Neurol Sci 109:1–10

    Article  PubMed  CAS  Google Scholar 

  18. Sanna T, Dello Russo A, Toniolo D, Vytopil M, Pelargonio G, De Martino G, Ricci E, Silvestri G, Giglio V, Messano L, Zachara E, Bellocci F (2003) Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J 24:2227–2236

    Article  PubMed  CAS  Google Scholar 

  19. Schwartz ML, Colan SD (2003) Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol 92:636–639

    Article  PubMed  Google Scholar 

  20. Stöllberger C, Finsterer J (2007) Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy. Clin Cardiol 30:375–380

    Article  PubMed  Google Scholar 

  21. Verny C, de Gennes C, Sébastien P, Lê Thi HD, Chapelon C, Piette JC, Chomette G, Godeau P (1992) Heart conduction disorders in long-term treatment with chloroquine. Two new cases. Presse Med 21:800–804

    PubMed  CAS  Google Scholar 

  22. Willemsen MA, van Oort AM, ter Laak HJ, Sengers RC, Gabreëls FJ (1997) Multicore myopathy with restrictive cardiomyopathy. Acta Paediatr 86: 1271–1274

    Article  PubMed  CAS  Google Scholar 

  23. Wöhrle J, Marx N, Koenig W, Hombach V, Kestler HA, Höher M, Nusser T (2008) Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease. Clin Res Cardiol 97:726–733

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Krankenanstalt Rudolfstiftung, Postfach 20, 1180, Vienna, Austria

    Josef Finsterer MD, PhD

  2. Second Medical Department, Krankenanstalt Rudolfstiftung, Vienna, Austria

    Claudia Stöllberger MD

Authors
  1. Josef Finsterer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Stöllberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josef Finsterer MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finsterer, J., Stöllberger, C. Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy. Clin Res Cardiol 98, 271–274 (2009). https://doi.org/10.1007/s00392-009-0757-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0757-y

Keywords

Search

Navigation